Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Genotropin Safety in SGA Children
NCT01859949Phase 4Completed
- Sponsor
- Pfizer
- Start
- Oct 2002
- Primary completion
- Aug 2015
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of genotropin miniquick in short stature, sponsored by Pfizer. Primary endpoint: Number of Participants With Adverse Events and Serious Adverse Events. Started Oct 2002; status: completed.
02
Drugs
genotropin miniquick
03
Conditions
short stature
Beyond the preview
Go deeper on NCT01859949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01859949.